Prelude therapeutics to participate in two upcoming healthcare investor conferences

Wilmington, del., feb. 09, 2023 (globe newswire) -- prelude therapeutics incorporated (prelude) (nasdaq: prld), a clinical-stage precision oncology company, announced today that the company will participate in three healthcare investment conferences in february.

PRLD Ratings Summary

PRLD Quant Ranking